Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects.

Vardas E, Stanescu I, Leinonen M, Ellefsen K, Pantaleo G, Valtavaara M, Ustav M, Reijonen K.

Vaccine. 2012 Jun 8;30(27):4046-54. doi: 10.1016/j.vaccine.2012.04.007.

PMID:
22549090
2.

Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate.

Bellino S, Francavilla V, Longo O, Tripiciano A, Paniccia G, Arancio A, Fiorelli V, Scoglio A, Collacchi B, Campagna M, Lazzarin A, Tambussi G, Din CT, Visintini R, Narciso P, Antinori A, D'Offizi G, Giulianelli M, Carta M, Di Carlo A, Palamara G, Giuliani M, Laguardia ME, Monini P, Magnani M, Ensoli F, Ensoli B.

Rev Recent Clin Trials. 2009 Sep;4(3):195-204. Review.

PMID:
20028332
3.

Therapeutic immunization for the control of HIV-1: where are we now?

Dorrell L.

Int J STD AIDS. 2006 Jul;17(7):436-41; quiz 442. Review.

PMID:
16820070

Supplemental Content

Support Center